دورية أكاديمية

Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.

التفاصيل البيبلوغرافية
العنوان: Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
المؤلفون: Trindade MA; Laboratório de Investigação Médica (LIM-56), Imunodermatologia, Hospital das Clínicas da Universidade de São Paulo, Dr Enéas Carvalho Aguiar 470, 3 andar, prédio 2 Instituto de Medicina Tropical, São Paulo, 05403900, Brazil. angelatrindade@uol.com.br.; Departamento de Dermatologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. angelatrindade@uol.com.br.; Rua Cristiano Viana 450, 163, Jardim Paulista, São Paulo, SP, CEP: 05411 000, Brazil. angelatrindade@uol.com.br.; Posgraduação Instituto de Saúde, Secretaria de Estado da Saúde de São Paulo, São Paulo, Brazil. angelatrindade@uol.com.br., Silva LL; Departamento de Dermatologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. lana_luiza@hotmail.com., Braz LM; Laboratorio de Parasitologia, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil. lmabraz@usp.br., Amato VS; Departamento de Doenças Infecciosas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. valdiramato@usp.br., Naafs B; Stichting Global Dermatology, Munnekeburen, The Netherlands. benaafs@dds.nl., Sotto MN; Departamento de Patologia e Dermatologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. mnsotto@usp.br.
المصدر: BMC infectious diseases [BMC Infect Dis] 2015 Nov 23; Vol. 15, pp. 543. Date of Electronic Publication: 2015 Nov 23.
نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Coinfection/*diagnosis , Leishmaniasis, Cutaneous/*complications , Leishmaniasis, Visceral/*complications , Leprosy/*complications, Amphotericin B/therapeutic use ; Antiprotozoal Agents/therapeutic use ; Brazil ; Coinfection/drug therapy ; Coinfection/microbiology ; Coinfection/parasitology ; Female ; Humans ; Leishmaniasis, Cutaneous/diagnosis ; Leishmaniasis, Cutaneous/drug therapy ; Leishmaniasis, Visceral/diagnosis ; Leishmaniasis, Visceral/drug therapy ; Leprosy/drug therapy ; Leprosy/pathology ; Macrophages/parasitology ; Macrophages/pathology ; Middle Aged ; Skin/parasitology ; Skin/pathology
مستخلص: Background: Post-kala-azar dermal leishmaniasis (PKDL) is a dermal complication of visceral leishmaniasis (VL), which may occur after or during treatment. It has been frequently reported from India and the Sudan, but its occurrence in South America has been rarely reported. It may mimic leprosy and its differentiation may be difficult, since both diseases may show hypo-pigmented macular lesions as clinical presentation and neural involvement in histopathological investigations. The co-infection of leprosy and VL has been reported in countries where both diseases are endemic. The authors report a co-infection case of leprosy and VL, which evolved into PKDL and discuss the clinical and the pathological aspects in the patient and review the literature on this disease.
Case Presentation: We report an unusual case of a 53-year-old female patient from Alagoas, Brazil. She presented with leprosy and a necrotizing erythema nodosum, a type II leprosy reaction, about 3 month after finishing the treatment (MDT-MB) for leprosy. She was hospitalized and VL was diagnosed at that time and she was successfully treated with liposomal amphotericin B. After 6 months, she developed a few hypo-pigmented papules on her forehead. A granulomatous inflammatory infiltrate throughout the dermis was observed at histopathological examination of the skin biopsy. It consisted of epithelioid histiocytes, lymphocytes and plasma cells with the presence of amastigotes of Leishmania in macrophages (Leishman's bodies). The diagnosis of post-kala-azar dermal leishmaniasis was established because at this time there was no hepatosplenomegaly and the bone marrow did not show Leishmania parasites thus excluding VL. About 2 years after the treatment of PKDL with liposomal amphotericin B the patient is still without PKDL lesions.
Conclusion: Post-kala-azar dermal leishmaniasis is a rare dermal complication of VL that mimics leprosy and should be considered particularly in countries where both diseases are endemic. A co-infection must be seriously considered, especially in patients who are non-responsive to treatment or develop persistent leprosy reactions as those encountered in the patient reported here.
References: Case Rep Med. 2013;2013:351579. (PMID: 23533426)
J Trop Med. 2013;2013:150746. (PMID: 23935641)
Parasit Vectors. 2013;6:196. (PMID: 23819611)
Acta Trop. 2000 Feb 25;75(1):35-8. (PMID: 10708005)
J Health Popul Nutr. 2013 Jun;31(2):294-7. (PMID: 23930349)
J Immunol. 2007 Oct 15;179(8):5592-603. (PMID: 17911647)
Ann Trop Med Parasitol. 2002 Dec;96(8):765-72. (PMID: 12625930)
Am J Trop Med Hyg. 2014 Jul;91(1):81-3. (PMID: 24732458)
Dermatol Clin. 2015 Jul;33(3):579-93. (PMID: 26143433)
Trans R Soc Trop Med Hyg. 2001 Apr;95 Suppl 1:S59-76. (PMID: 11370251)
Int J Dermatol. 2014 May;53(5):606-8. (PMID: 24321013)
Am J Trop Med Hyg. 2009 Mar;80(3):336-8. (PMID: 19270277)
Int J Dermatol. 2008 Apr;47(4):414-6. (PMID: 18377613)
Indian J Dermatol Venereol Leprol. 1999 Jul-Aug;65(4):196. (PMID: 20921656)
J Infect Dis. 1986 Dec;154(6):1003-11. (PMID: 3782864)
Biomed Res Int. 2015;2015:745062. (PMID: 26090441)
Braz J Infect Dis. 2003 Jun;7(3):229-33. (PMID: 14499047)
J Cutan Pathol. 2003 Nov;30(10):616-20. (PMID: 14744086)
Am J Trop Med Hyg. 1991 May;44(5):536-46. (PMID: 2063957)
Lepr Rev. 1993 Mar;64(1):53-9. (PMID: 8464317)
Br J Dermatol. 2000 Jul;143(1):136-43. (PMID: 10886148)
Br J Dermatol. 2007 Oct;157(4):811-3. (PMID: 17627788)
Am J Trop Med Hyg. 1993 Nov;49(5):616-24. (PMID: 8250102)
Curr Opin Infect Dis. 2011 Oct;24(5):418-22. (PMID: 21885919)
Rev Inst Med Trop Sao Paulo. 2013 Nov-Dec;55(6):429-31. (PMID: 24213198)
Clin Exp Immunol. 1998 Jan;111(1):64-9. (PMID: 9472662)
Int J Dermatol. 1992 Jun;31(6):400-3. (PMID: 1512091)
Indian J Med Res. 2006 Mar;123(3):295-310. (PMID: 16778312)
Trends Parasitol. 2014 Feb;30(2):65-74. (PMID: 24388776)
Indian J Dermatol Venereol Leprol. 2005 Jul-Aug;71(4):250-3. (PMID: 16394433)
Int J Dermatol. 2011 Sep;50(9):1099-108. (PMID: 22126871)
Int J Dermatol. 2009 Jul;48(7):740-2. (PMID: 19570081)
Lancet Infect Dis. 2003 Feb;3(2):87-98. (PMID: 12560194)
Int J Dermatol. 2004 Jun;43(6):428-9. (PMID: 15186223)
Clin Microbiol Rev. 1993 Jul;6(3):230-50. (PMID: 8358705)
Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):360-6. (PMID: 23619440)
Diagn Microbiol Infect Dis. 2003 Sep;47(1):349-58. (PMID: 12967749)
Int J Dermatol. 2013 Jul;52(7):897-9. (PMID: 23675968)
Int J Dermatol. 2010 Aug;49(8):921-31. (PMID: 21128917)
المشرفين على المادة: 0 (Antiprotozoal Agents)
0 (liposomal amphotericin B)
7XU7A7DROE (Amphotericin B)
تواريخ الأحداث: Date Created: 20151124 Date Completed: 20160315 Latest Revision: 20181202
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4656188
DOI: 10.1186/s12879-015-1260-x
PMID: 26592919
قاعدة البيانات: MEDLINE